AKT1 and lip and oral cavity carcinoma: Aberration in the EGFR-PI3K-AKT pathways is a hallmark for oral cancer, where the cytoplasmatic phosphorylated form of AKT is expressed in more than 64% of cases [151,152,153] (Figure 4).